Rang	Name	Position
1	Mr. Brenton L. Saunders J.D.	CEO & Director
2	Mr. Osama A. Eldessouky	Executive VP & CFO
3	Mr. A. Robert D. Bailey	Executive VP & Chief Legal Officer
4	Dr. Yehia Hashad M.D., Ph.D.	Executive VP of Research & Development and Chief Medical officer
5	Mr. Andrew J. Stewart	President of Global Pharmaceuticals & International Consumer
6	Mr. Alan Waterhouse CPFA, MBA	Executive VP and Chief Supply Chain & Operations Officer
7	Mr. Frederick J. Munsch	Senior VP, Controller & Chief Accounting Officer
8	Mr. George Gadkowski	VP & Head of Investor Relations & Business Insights
9	Mr. Jonathon L. Kellerman	Chief Compliance Officer
10	Mr. T.J. Crawford	Chief Communications Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Deutsche Bank AG	0,99%	0,06 Mrd. USD
2	ICAHN CARL C	0,98%	0,06 Mrd. USD
3	Oaktree Capital Management LLC	0,95%	0,06 Mrd. USD
4	D. E. Shaw & Co LP	0,93%	0,06 Mrd. USD
5	Goldentree Asset Management LP	0,74%	0,05 Mrd. USD
6	Davidson Kempner Capital Management LP	0,62%	0,04 Mrd. USD
7	Caspian Capital Partners, L.P.	0,56%	0,03 Mrd. USD
8	Glenview Capital Management LLC	0,54%	0,03 Mrd. USD
9	T. Rowe Price Associates, Inc.	0,34%	0,02 Mrd. USD
10	Whitebox Advisors, LLC	0,31%	0,02 Mrd. USD
11	Citadel Advisors Llc	0,28%	0,02 Mrd. USD
12	Arrowstreet Capital Limited Partnership	0,28%	0,02 Mrd. USD
13	Clark Estates Inc	0,25%	0,02 Mrd. USD
14	Morgan Stanley - Brokerage Accounts	0,24%	0,02 Mrd. USD
15	Clearline Capital LP	0,20%	0,01 Mrd. USD
16	GordonMD Global Investments LP	0,16%	0,01 Mrd. USD
17	Tudor Investment Corp Et AL	0,15%	0,01 Mrd. USD
18	UBS Group AG	0,13%	0,01 Mrd. USD
19	Woodline Partners LP	0,11%	0,01 Mrd. USD
20	Jane Street Group LLC	0,09%	0,01 Mrd. USD